Ranking · Summer 2020 · Healthcare · Drug Discovery and Delivery

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

6.1%

odds of being acquired in the next two years

0.9× the average (6.8%)

#2554 of 4,339 active YC companies · top 60%

Team of 15 · New York City, NY, USA; New York, NY, USA; Remote

Raises the odds

↑ based in Fully Remote

↑ based in United States of America

↑ based in America / Canada

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Gilgamesh Pharmaceuticals's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

gilgameshpharmaceutical.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub